113 related articles for article (PubMed ID: 36781201)
1. Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
Loncar G; Garfias-Veitl T; Valentova M; Vatic M; Lainscak M; Obradović D; Dschietzig TB; Doehner W; Jankowska EA; Anker SD; von Haehling S
Eur J Heart Fail; 2023 May; 25(5):714-723. PubMed ID: 36781201
[TBL] [Abstract][Full Text] [Related]
2. Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study.
Fohtung RB; Brown DL; Koh WJ; Bartz TM; Carbone LD; Civitelli R; Stein PK; Chaves PH; Kestenbaum BR; Kizer JR
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28288973
[TBL] [Abstract][Full Text] [Related]
3. Relationship between bone mineral density and serum osteoprotegerin in patients with chronic heart failure.
Chen YH; Wu YW; Yang WS; Wang SS; Lee CM; Chou NK; Hsu RB; Lin YH; Lin MS; Ho YL; Chen MF
PLoS One; 2012; 7(8):e44242. PubMed ID: 22957004
[TBL] [Abstract][Full Text] [Related]
4. Higher levels of s-RANKL and osteoprotegerin in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast signaling and predisposition to lower bone mass: a multivariate cross-sectional analysis.
Tsentidis C; Gourgiotis D; Kossiva L; Doulgeraki A; Marmarinos A; Galli-Tsinopoulou A; Karavanaki K
Osteoporos Int; 2016 Apr; 27(4):1631-1643. PubMed ID: 26588909
[TBL] [Abstract][Full Text] [Related]
5. Sex- and race-specific associations of bone mineral density with incident heart failure and its subtypes in older adults.
Gao H; Patel S; Fohtung RB; Cawthon PM; Newman AB; Cauley JA; Carbone L; Chaves PHM; Stein PK; Civitelli R; Kizer JR
J Am Geriatr Soc; 2023 Mar; 71(3):742-755. PubMed ID: 36334030
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of the bone turnover markers dickkopf-1, sclerostin, osteoprotegerin, osteopontin, osteocalcin and 25-hydroxyvitamin D in Swedish geriatric patients aged 75 years or older with a fresh hip fracture and in healthy controls.
Wanby P; Nobin R; Von SP; Brudin L; Carlsson M
J Endocrinol Invest; 2016 Aug; 39(8):855-63. PubMed ID: 26850415
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
Valero C; Olmos JM; Rivera F; Hernández JL; Vega ME; Macías JG
Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
[TBL] [Abstract][Full Text] [Related]
8. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.
Shane E; Mancini D; Aaronson K; Silverberg SJ; Seibel MJ; Addesso V; McMahon DJ
Am J Med; 1997 Sep; 103(3):197-207. PubMed ID: 9316552
[TBL] [Abstract][Full Text] [Related]
9. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
[TBL] [Abstract][Full Text] [Related]
10. Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Dobnig H; Hofbauer LC; Viereck V; Obermayer-Pietsch B; Fahrleitner-Pammer A
Osteoporos Int; 2006; 17(5):693-703. PubMed ID: 16435076
[TBL] [Abstract][Full Text] [Related]
11. Lower P1NP serum levels: a predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients.
Seguro LP; Casella CB; Caparbo VF; Oliveira RM; Bonfa A; Bonfa E; Pereira RM
Osteoporos Int; 2015 Feb; 26(2):459-67. PubMed ID: 25146092
[TBL] [Abstract][Full Text] [Related]
12. Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis.
Lu CW; Wang CH; Hsu BG; Tsai JP
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440966
[TBL] [Abstract][Full Text] [Related]
13. Bone Turnover Markers and Bone Mineral Density to Predict Osteoporotic Fractures in Older Women: A Retrospective Comparative Study.
Qu XL; Zheng B; Chen TY; Cao ZR; Qu B; Jiang T
Orthop Surg; 2020 Feb; 12(1):116-123. PubMed ID: 31880071
[TBL] [Abstract][Full Text] [Related]
14. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
15. A common polymorphism rs1800247 in osteocalcin gene was associated with serum osteocalcin levels, bone mineral density, and fracture: the Shanghai Changfeng Study.
Ling Y; Gao X; Lin H; Ma H; Pan B; Gao J
Osteoporos Int; 2016 Feb; 27(2):769-79. PubMed ID: 26194493
[TBL] [Abstract][Full Text] [Related]
16. Predictors of bone mass in healthy older men in the community.
Smerdely P; Seller M; Smith A; Day P; Diamond T
Med J Aust; 2000 Aug; 173(4):183-6. PubMed ID: 11008590
[TBL] [Abstract][Full Text] [Related]
17. Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study.
Xu Y; Shen L; Liu L; Zhang Z; Hu W
Front Endocrinol (Lausanne); 2022; 13():843912. PubMed ID: 35898467
[TBL] [Abstract][Full Text] [Related]
18. Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy.
Hoy J; Grund B; Roediger M; Ensrud KE; Brar I; Colebunders R; Castro ND; Johnson M; Sharma A; Carr A;
J Bone Miner Res; 2013 Jun; 28(6):1264-74. PubMed ID: 23299909
[TBL] [Abstract][Full Text] [Related]
19. Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism.
Sharma J; Itum DS; Moss L; Li C; Weber C
World J Surg; 2014 Jun; 38(6):1268-73. PubMed ID: 24744114
[TBL] [Abstract][Full Text] [Related]
20. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
